Neurobo Pharmaceuticals Buy Hold or Sell Recommendation
| NRBODelisted Stock | USD 1.89 0.11 5.50% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Neurobo Pharmaceuticals is 'Not Rated'. The recommendation algorithm takes into account all of Neurobo Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. In addition, we conduct extensive research on individual companies such as Neurobo and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Neurobo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Neurobo |
Execute Neurobo Pharmaceuticals Buy or Sell Advice
The Neurobo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Neurobo Pharmaceuticals. Macroaxis does not own or have any residual interests in Neurobo Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Neurobo Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
2 Years |
Risk Tolerance
I am willing to take any risk |
 |  |
Not Rated
Neurobo Pharmaceuticals Trading Alerts and Improvement Suggestions
| Neurobo Pharmaceuticals is now traded under the symbol MTVA. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Neurobo Pharmaceuticals is not yet fully synchronised with the market data | |
| Neurobo Pharmaceuticals generated a negative expected return over the last 90 days | |
| Neurobo Pharmaceuticals has high historical volatility and very poor performance | |
| Neurobo Pharmaceuticals may become a speculative penny stock | |
| Neurobo Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 7 K. Net Loss for the year was (12.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Neurobo Pharmaceuticals currently holds about 8.85 M in cash with (10.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 65.0% of the company outstanding shares are owned by corporate insiders |
Neurobo Pharmaceuticals Returns Distribution Density
The distribution of Neurobo Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Neurobo Pharmaceuticals' future price movements. The chart of the probability distribution of Neurobo Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Neurobo Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Neurobo Pharmaceuticals returns is essential to provide solid investment advice for Neurobo Pharmaceuticals.
| Mean Return | -0.47 |
| Value At Risk | -7.34 |
| Potential Upside | 8.05 |
| Standard Deviation | 5.38 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Neurobo Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Strickland D Gordon of 12500 shares of Neurobo Pharmaceuticals subject to Rule 16b-3 [view details]
Neurobo Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Neurobo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Neurobo Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Neurobo Pharmaceuticals? Buying financial instruments such as Neurobo Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Neurobo Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Gold and Gold Mining Thematic Idea Now
Gold and Gold Mining
Large and mid-size companies, ETFs and funds that are either investing, exploring or producing, gold or indirectly involved in trading or making gold products. The Gold and Gold Mining theme has 73 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gold and Gold Mining Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Neurobo Stock
If you are still planning to invest in Neurobo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobo Pharmaceuticals' history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |